Related Experiment Video
Updated: May 14, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
The role of ADAM17 in metabolic inflammation
Rossella Menghini1, Loredana Fiorentino, Viviana Casagrande
1Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
Abstract:
The TNF-alpha Converting Enzyme (TACE), also called ADAM17 (A Disintegrin and A Metalloproteinase 17) is a type I transmembrane metalloproteinase involved in the shedding of the extracellular domain of several transmembrane proteins such as cytokines, growth factors, receptors and adhesion molecules. Some of these proteolytic events are part of cleavage cascades known as Regulated Intramembrane Proteolysis and lead to intracellular signaling. Evidence is provided that ADAM17 plays a role in atherosclerosis, in adipose tissue metabolism, insulin resistance and diabetes. The multitude of substrates cleaved by ADAM17 makes this enzyme an attractive candidate to study its role in inflammatory disorders. This review is focused on effects of ADAM17 in major metabolic tissues.
Insights
The TNF-alpha Converting Enzyme (TACE), or ADAM17, cleaves proteins involved in cell signaling. This review explores ADAM17's role in metabolic tissues, impacting conditions like diabetes and atherosclerosis.
Area of Science:
- Biochemistry
- Molecular Biology
- Metabolic Research
Background:
- ADAM17 (A Disintegrin and A Metalloproteinase 17), also known as TACE, is a metalloproteinase.
- It mediates the shedding of various transmembrane proteins, influencing cell signaling pathways.
- ADAM17 is implicated in inflammatory disorders and metabolic diseases.
Purpose of the Study:
- To review the role of ADAM17 in major metabolic tissues.
- To highlight ADAM17's involvement in atherosclerosis, adipose tissue metabolism, insulin resistance, and diabetes.
Main Methods:
- Literature review of studies on ADAM17 function.
- Analysis of ADAM17 substrate cleavage and its physiological consequences.
- Focus on ADAM17's impact on key metabolic tissues.
Main Results:
- ADAM17 participates in regulated intramembrane proteolysis, affecting intracellular signaling.
- Evidence links ADAM17 activity to the pathogenesis of atherosclerosis.
- ADAM17 plays a significant role in adipose tissue metabolism and insulin resistance.
Conclusions:
- ADAM17 is a critical enzyme in metabolic regulation.
- Targeting ADAM17 may offer therapeutic strategies for metabolic and inflammatory diseases.
- Further research into ADAM17 substrates and functions in metabolic tissues is warranted.
Related Concept Videos
Regulation of Metabolism
Regulation of the Unfolded Protein Response
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Acute Inflammation I: Inflammatory Response

